Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS_Steatohepatitis progresses to cancer via immunosuppression of HCC

ABSTRACT: Steatohepatitis progresses to cancer via immunosuppression of HCC

INSTRUMENT(S): maXis

ORGANISM(S): Mus Musculus (ncbitaxon:10090)

SUBMITTER: Karin

PROVIDER: MSV000080558 | GNPS | Tue Feb 21 12:04:00 GMT 2017

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

JOSD1 facilitates colorectal cancer progression via stabilizing YAP

Project description:JOSD1 facilitates colorectal cancer progression via stabilizing YAP

| PRJNA1078851 | ENA

GNPS_Steatohepatitis progresses to cancer via immunosuppression of HCC directed CD8+ T cells

Project description:Steatohepatitis progresses to cancer via immunosuppression of HCC directed CD8+ T cells LC/MS data of intestinal content in murine model. Multiple categories associated with normal and high fat diet, NAFLD, NASH and HCC are included.

2017-04-13 | MSV000080918 | GNPS

Myocardial Infarction accelerates breast cancer via innate immune reprogramming

Project description:Myocardial Infarction accelerates breast cancer via innate immune reprogramming

| PRJNA573069 | ENA

Tracing back primed resistance in cancer via sister cells

Project description:Tracing back primed resistance in cancer via sister cells

| PRJNA924690 | ENA

Cancer immunotherapy via synergistic co-activation of myeloid cells

Project description:Cancer immunotherapy via synergistic co-activation of myeloid cells

| PRJNA975167 | ENA

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer

Project description:HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer

| PRJNA732187 | ENA

Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancer

Project description:Pancreatic cancer is characterized by a high frequency of cachexia, pain and neural invasion (N-inv). Neural damage is occurred by N-inv and modulates pain and muscle atrophy via the activation of astrocyte in the connected spine. The activated astrocyte by N-inv, thus, may affect cachexia in pancreatic cancer. Clinical studies in patients and autopsy cases with pancreatic cancer have revealed that N-inv is related to cachexia and astrocytic activation. We established a novel murine model of cancer cachexia using N-inv of human pancreatic cancer cells. Mice with N-inv showed a loss of body weight, skeletal muscle, and fat mass without appetite loss, which are compatible with an animal model of cancer cachexia. Activation of astrocytes in the spinal cord connected with N-inv was observed in our model. Experimental cachexia was suppressed by disrupting neural routes or inhibiting the activation of astrocytes. These data provide the first evidence that N-inv induces cachexia via astrocytic activation of neural route in pancreatic cancer. We produced neural invasion (N-inv) model using intraneural injection of Capan-1 cells to left sciatic nerve of male SCID mouse. For controls, subcutaneous model (SC) and PBS model were produced. Microarray analysis was performed using the first lumbar cord (L1) from PBS, SC, and N-inv mice at 6 w (n = 2 each).

2011-12-07 | E-GEOD-34189 | biostudies-arrayexpress

Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

Project description:Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

| PRJNA888090 | ENA

Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

Project description:Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

| PRJNA888094 | ENA

Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

Project description:Targeting DCAF5 suppresses SMARCB1-mutant cancer via stabilizing SWI/SNF

| PRJNA888095 | ENA